News & Publications

October 25, 2018 – Article CMS Seeks to Revamp Medicare Part B Drug Reimbursement through Proposed International Pricing Index (IPI) Model Health Law Advisor Blog John S. Linehan, Constance A. Wilkinson

October 19, 2018 – Article New Federal Laws Banning “Gag Clauses” in the Pharmacy Health Law Advisor Blog Lynn Shapiro Snyder, John S. Linehan, Alan J. Arville, Audrey Davis

January 3, 2018 – Client Alerts Comment Deadline Approaches for CMS’s Proposed Changes to Medicare Advantage and Part D Programs for CY 2019 – Part 2: Beneficiary Cost, Access, and Protection Health Care and Life Sciences Client Alert Constance A. Wilkinson, Alan J. Arville, Helaine I. Fingold, John S. Linehan, James S. Tam

January 3, 2018 – Client Alerts Comment Deadline Approaches for CMS’s Proposed Changes to Medicare Advantage and Part D Programs for CY 2019 – Part 1: Negotiated Prices for Drugs Health Care and Life Sciences Client Alert Constance A. Wilkinson, John S. Linehan, James S. Tam

May 2017 – Video Trends in Drug Pricing and Reimbursement: Thought Leaders in Health Law Video Series

April 7, 2017 – In the News John Linehan Quoted in “PBM Executive Pleads Guilty in $3.5 Million Kickback Scheme” Drug Benefit News

March 24, 2017 – In the News Epstein Becker Green’s Successful Defense of False Claims Act Case Noted in Multiple Publications Multiple Publications

January 17, 2017 – In the News John Linehan Quoted in “Path of Uncertainty: Pharm Exec’s 2017 Industry Forecast” PharmExec.com

December 14, 2016 – Article The Future Impact of Populism on Drug Pricing Reform Health Law Advisor John S. Linehan

December 8, 2016 – Article Conflicting State Compounding Regulations Create Barriers for FDA-Registered Outsourcing Facilities Specialty Pharmacy Times John S. Linehan

December 8, 2016 – Article Politics, Populism, and the Future of Prescription Drug Pricing Reform PharmExec.com John S. Linehan

March 23, 2016 – Article Drug Compounding: Cause and Cure for High Drug Prices? PharmExec.com

February 25, 2016 – Client Alerts CMS Proposes Modest Increases to Medicare Advantage and Part D Plan Payment Rates Accompanied by Significant Revisions to Risk Adjustment Methodologies and Employer/Union-Only Group Welfare Plan Bids Health Care and Life Sciences Client Alert Thomas E. Hutchinson, Helaine I. Fingold, Philo D. Hall, Richard H. Hughes IV, John S. Linehan, M. Brian Hall IV

January 29, 2016 – Client Alerts CMS Issues Final Rule on Covered Outpatient Drugs Health Care and Life Sciences Client Alert Constance A. Wilkinson, Alan J. Arville, Lesley R. Yeung, John S. Linehan, Richard H. Hughes IV, Meghan F. Weinberg, James S. Tam

December 14, 2015 – Client Alerts California Imposes Controversial Cost-Sharing Restrictions to Facilitate Patient Access to Expensive Drugs Health Care and Life Sciences Client Alert John S. Linehan

October 5, 2015 – Client Alerts West Coast States Bolster Momentum for Pharmacist Provider Status Reforms Health Care and Life Sciences Client Alert John S. Linehan

June 1, 2015 – Article FDA Signals Tougher Approach to Animal Drug Compounding Law360 James A. Boiani, John S. Linehan

May 28, 2015 – Client Alerts FDA Signals Restrictive Regulatory Approach in Draft Guidance on Animal Drug Compounding Health Care and Life Sciences Client Alert James A. Boiani, John S. Linehan

May 7, 2015 – Client Alerts CMS Amends Medicare Part D Program Integrity Regulations to Facilitate Beneficiary Access and Expand Coverage for Pharmacist Prescribers Health Care and Life Sciences Client Alert Thomas E. Hutchinson, John S. Linehan

April 14, 2015 – In the News Client Alert by Hutchinson, Kocot, Linehan Mentioned in “CMS Issues 2016 Parameters for ‘Creditable’ Drug Coverage” SHRM.org

April 10, 2015 – Client Alerts 2016 Payment Notice and Final Call Letter: CMS Gives with One Hand and Takes Away with the Other Health Care and Life Sciences Client Alert Thomas E. Hutchinson, S. Lawrence Kocot, John S. Linehan

December 10, 2014 – Client Alerts CMS Seeks Comments on Proposed Enhancements and Modifications to the Star Ratings for Medicare Advantage and Part D Prescription Drug Plans Health Care and Life Sciences Client Alert Helaine I. Fingold, John S. Linehan

December 4, 2014 – Client Alerts Medicare Shared Savings Program Proposed Rule: Enough Incentive to Encourage More ACO Risk? Health Care and Life Sciences Client Alert S. Lawrence Kocot, Thomas E. Hutchinson, John S. Linehan, Philo D. Hall, Meghan F. Weinberg

November 2014 – Article The Legal Implications of Pharmacist Provider Status and the Transformation of an Industry AHLA Connections John S. Linehan

February 3, 2014 – Article As Preferred Pharmacy Networks Become Prominent, Legal Hurdles Remain Health Briefs E-Newsletter, Healthcare Liability and Litigation Practice Group, American Health Lawyers Association

December 31, 2013 – Article The Judge Doth Reject: How to Prepare for Increased Judicial Scrutiny of Corporate Settlement Agreements in Health Care Cases White Collar Crime Committee Newsletter, American Bar Association John S. Linehan

February 1, 2012 – Article Fostering Healthcare Reform through a Bifurcated Model of Fraud and Abuse Regulation Journal of Health & Life Sciences Law

January 16, 2012 – Article Understanding the Use of Misdemeanors in Healthcare Enforcement AHLA Connections, American Health Lawyers Association

John S. Linehan, Senior Counsel

News & Publications